Back
AbbVie Stock Predictions
Sponsored
ABBV
Sponsored
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
57
ABBV
AbbVie
Last Price:
201.69
Seasonality Move:
5.62%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE TradeAbbVie Stock Forecast
- Over the next 52 weeks, AbbVie has on average historically risen by 15.9% based on the past 11 years of stock performance.
- AbbVie has risen higher in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
-
Is AbbVie Stock Undervalued?
The current AbbVie [ABBV] share price is $201.68. The Score for ABBV is 57, which is 14% above its historic median score of 50, and infers lower risk than normal. - ABBV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will AbbVie Stock Go Up Next Year?
- Over the next 52 weeks, AbbVie has on average historically risen by 15.9% based on the past 11 years of stock performance.
AbbVie Stock Rating
Buy
57
AbbVie (ABBV)
is a Buy
Is AbbVie overpriced?
- AbbVie has risen higher in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
AbbVie Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
abbvieinvestor.com
52-Week Data
52-Week High:
207.32
52-Week Low:
135.85
Prediction Charts
Market Cap:
356.4B
Price in USD:
201.68
Volume:
5.1M
Beta:
0.81
Technical Analysis
SMA50:
194.46
SMA100:
186.69
SMA200:
178.17
52-Wk Change:
42.61%
Stock Predictions
-
Is AbbVie stock public?
Yes, AbbVie is a publicly traded company. -
What is the AbbVie stock quote today?
The AbbVie stock price is 201.68 USD today. -
How to buy AbbVie stock online?
You can buy AbbVie shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-16 | 190.45 | 190.46 | 191.04 | 188.73 |
Oct-18 | 188.97 | 188.86 | 189.69 | 188.16 |
Oct-21 | 188.71 | 186.54 | 189.38 | 185.89 |
Oct-22 | 186.32 | 188.76 | 189.10 | 186.23 |
Oct-23 | 188.70 | 187.88 | 189.27 | 187.50 |
Oct-24 | 188.43 | 189.65 | 190.47 | 188.17 |
Oct-25 | 189.68 | 187.85 | 189.88 | 187.17 |
Oct-28 | 188.09 | 189.68 | 190.14 | 187.52 |
Oct-29 | 190.49 | 189.45 | 191.16 | 188.52 |
Oct-30 | 191.62 | 201.50 | 202.35 | 188.55 |
Oct-31 | 201.97 | 203.87 | 207.32 | 201.42 |
Nov-1 | 204.37 | 203.55 | 204.73 | 202.32 |
Nov-4 | 203.79 | 200.47 | 204.24 | 200.22 |
Nov-5 | 200.49 | 201.68 | 202.42 | 198.35 |
AbbVie Earnings
AbbVie Earnings Report: Per Share AbbVie Earnings Q1 Q2 Q3 and Q4 last year and next year.
AbbVie Forecast Revenue Growth
AbbVie Stock Analysis: Historical quarterly revenues per share for AbbVie and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $1.15 per share.
* AbbVie stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.